Minor Correction in Proxy Solicitation by Enzychem Lifesciences Minority Shareholder, No Change to Agenda
Nam Yun-hee has corrected a typographical error in the proxy form of the solicitation document and added a PDF attachment.
This correction is a mere clerical fix and does not affect the existing agenda items or the direction of proxy voting.
[AI Summary]This amendment is limited to a proxy form correction with no impact on shareholder value. As there are no financial changes, a neutral stance is maintained.
KOSDAQ Filing Information
[Correction of Attachment] Proxy Solicitation Reference Documents